Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy vTv Therapeutics stock | $1.47

Learn how to easily invest in vTv Therapeutics stock.

vTv Therapeutics Inc is a biotechnology business based in the US. vTv Therapeutics shares (VTVT) are listed on the NASDAQ and all prices are listed in US Dollars. vTv Therapeutics employs 25 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in vTv Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VTVT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

vTv Therapeutics stock price (NASDAQ: VTVT)

Use our graph to track the performance of VTVT stocks over time.

vTv Therapeutics shares at a glance

Information last updated 2021-10-17.
Latest market close$1.47
52-week range$1.46 - $3.59
50-day moving average $1.70
200-day moving average $2.16
Wall St. target price$6.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.10

Buy vTv Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy vTv Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

vTv Therapeutics price performance over time

Historical closes compared with the close of $1.47 from 2021-10-20

1 week (2021-10-14) -2.00%
1 month (2021-09-21) -14.04%
3 months (2021-07-21) -32.26%
6 months (2021-04-21) -39.51%
1 year (2020-10-21) -10.37%
2 years (2019-10-21) 4.26%
3 years (2018-10-19) 3.74
5 years (2016-10-21) 6.81

vTv Therapeutics financials

Revenue TTM $7.4 million
Gross profit TTM $-4,601,000
Return on assets TTM -38.53%
Return on equity TTM -238.99%
Profit margin -71.01%
Book value $-1.67
Market capitalisation $122.4 million

TTM: trailing 12 months

Shorting vTv Therapeutics shares

There are currently 2.2 million vTv Therapeutics shares held short by investors – that's known as vTv Therapeutics's "short interest". This figure is 39.3% up from 1.6 million last month.

There are a few different ways that this level of interest in shorting vTv Therapeutics shares can be evaluated.

vTv Therapeutics's "short interest ratio" (SIR)

vTv Therapeutics's "short interest ratio" (SIR) is the quantity of vTv Therapeutics shares currently shorted divided by the average quantity of vTv Therapeutics shares traded daily (recently around 3.4 million). vTv Therapeutics's SIR currently stands at 0.64. In other words for every 100,000 vTv Therapeutics shares traded daily on the market, roughly 640 shares are currently held short.

However vTv Therapeutics's short interest can also be evaluated against the total number of vTv Therapeutics shares, or, against the total number of tradable vTv Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case vTv Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 vTv Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0944% of the tradable shares (for every 100,000 tradable vTv Therapeutics shares, roughly 94 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against vTv Therapeutics.

Find out more about how you can short vTv Therapeutics stock.

vTv Therapeutics share dividends

We're not expecting vTv Therapeutics to pay a dividend over the next 12 months.

vTv Therapeutics share price volatility

Over the last 12 months, vTv Therapeutics's shares have ranged in value from as little as $1.46 up to $3.59. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while vTv Therapeutics's is -1.6545. This would suggest that vTv Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, vTv Therapeutics has bucked the trend.

vTv Therapeutics overview

vTv Therapeutics Inc. , a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs. The company is developing TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant PDE4 inhibitor that addresses inflammatory diseases. It is also involved in the clinical development of other programs, including a small molecule GLP-1r agonist; the PDE4 inhibitor; HPP737, a PPAR-delta agonist; and an Nrf2 activator through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc.

Frequently asked questions

What percentage of vTv Therapeutics is owned by insiders or institutions?
Currently 60.967% of vTv Therapeutics shares are held by insiders and 7.31% by institutions.
How many people work for vTv Therapeutics?
Latest data suggests 25 work at vTv Therapeutics.
When does the fiscal year end for vTv Therapeutics?
vTv Therapeutics's fiscal year ends in December.
Where is vTv Therapeutics based?
vTv Therapeutics's address is: 3980 Premier Drive, High Point, NC, United States, 27265
What is vTv Therapeutics's ISIN number?
vTv Therapeutics's international securities identification number is: US9183851057
What is vTv Therapeutics's CUSIP number?
vTv Therapeutics's Committee on Uniform Securities Identification Procedures number is: 918385105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site